Experimentally, navitoclax kills cells in the BAX/BAK-dependent manner and brings about regression of lymphoid tumors in xenograft styles.In addition, we chose to irradiate cells 24 h just after cell seeding and drug administration to make certain total cell attachment ahead of irradiation.The pharmacodynamic consequences of navitoclax on circulat